Starling Oncology, Inc. (STLNW) Shareholders’ equity 2020–2025
Starling Oncology, Inc. (STLNW) shareholders’ equity at each fiscal year-end, per SEC filings.
-$15.7MFY2025 · since FY2020: $28.1M → -$15.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.7M | -538.0% |
| FY2024 | $3.6M | -93.7% |
| FY2023 | $57.0M | -53.7% |
| FY2022 | $123.2M | +18.3% |
| FY2021 | $104.2M | +270.7% |
| FY2020 | $28.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice